Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-15 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-15 inhibits the replication of influenza virus. Cap-dependent endonuclease-IN-15 has the potential for the research of viral infections caused by influenza viruses (extracted from patent CN113226327A, compound c-1)[1].
Web ID
– HY-143769
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C27H23F2N3O7Se
References
– [1]Xiaolin Hao, et al. Compounds useful in the treatment of influenza virus infection. Patent CN113226327A.
CAS Number
– 2581298-44-2
Molecular Weight
– 618.44
SMILES
– O=C(OC)OCOC(C(C=C1)=O)=C(N1N([C@@H]2C3=CC=CC=C3[Se]CC4=C(F)C(F)=CC=C24)[C@@]5([H])N6CCOC5)C6=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
